Uncertainty and excitement surround one company's cell therapy for epilepsy

After 10 years of work, Neurona may have the data to quiet its skeptics. But its ongoing clinical trial will be the ultimate test.

Episode metadata supplied by the publisher feed · Published Oct 24, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Uncertainty and excitement surround one company's cell therapy for epilepsy

0:00 19:54

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 19 minutes long.

This episode was published on October 24, 2023.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!